Market Cap 1.56B
Revenue (ttm) 0.00
Net Income (ttm) -227.32M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.39
Volume 5,474,900
Avg Vol 919,822
Day's Range N/A - N/A
Shares Out 73.62M
Stochastic %K 67%
Beta 1.04
Analysts Strong Sell
Price Target $32.54

Company Profile

MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases in dermatology and rheumatology, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerla...

Industry: Biotechnology
Sector: Healthcare
Phone: 41 415108022
Address:
Dorfstrasse 29, Zug, Switzerland
IronManResurrection
IronManResurrection Jun. 25 at 2:22 AM
$MLTX All jokes aside Jorge is now Walkstreet’s btch! The saving grace is they’re so greedy that they will get us to $150/share BO. Sit back and watch the machine work. You don’t drop $200M on a company to not 50x that shit.
0 · Reply
Timefortendies77
Timefortendies77 Jun. 25 at 1:55 AM
$MLTX It's funny how they graciously pinned it at 20 to end the day.
0 · Reply
septrading
septrading Jun. 25 at 1:25 AM
$MLTX in less than 6 months, UBC will be utter trash and we will be king of HS and much more. Wake up, folks!
0 · Reply
septrading
septrading Jun. 25 at 1:16 AM
$MLTX I've been blocking the bears and whiners all along. And the flippers, too. We move forward knowing there is a 7x+ win ahead. If you're not holding, just move on.
2 · Reply
Obidagreat
Obidagreat Jun. 25 at 1:04 AM
0 · Reply
Kodaspappy
Kodaspappy Jun. 25 at 12:34 AM
$MLTX Retail hype never ends well for me. I just don't have the kind of luck some of you do. This is the most patient I've ever been in a stock and I will remain so. Purchases today were in the 18.90s to 19.50s.
1 · Reply
ProVest1
ProVest1 Jun. 25 at 12:32 AM
$MLTX What kind of Buffoon does NOT do an offering in the $60’s but does two offerings when the stock is depressed and worth a third of its former value that’s DE-RISKED along with all kinds of good news and positive developments? These people are idiots or are getting horrible advice. Which is it? or both?
3 · Reply
septrading
septrading Jun. 25 at 12:26 AM
$MLTX arrogant MOFO says, Pay Up!
1 · Reply
Shaybe16569
Shaybe16569 Jun. 25 at 12:19 AM
$MLTX Won’t disagree here, I think Jorge has been managing the company poorly. Or, there is strategy behind the madness. Phenomenal science, poor execution so far.
1 · Reply
Modern_portholio_theory
Modern_portholio_theory Jun. 25 at 12:03 AM
$MLTX looking back to march 2023 there are some parallels between stock price and a prospectus, where mid march price starting to rise to low to mid 20’s from low teens several months prior prospectus issues later march dropped price back to teens by april it was recovering, may new highs, and june looked great- beyond that bounced up to 50s on m and a rumour https://www.sec.gov/Archives/edgar/data/1821586/000162828023009529/moonlake424b3.htm
0 · Reply
Latest News on MLTX
MoonLake Immunotherapeutics 9M share Secondary priced at $20.00

2026-06-24T10:25:15.000Z - 18 hours ago

MoonLake Immunotherapeutics 9M share Secondary priced at $20.00


MoonLake Immunotherapeutics Transcript: Investor Day 2026

Jun 22, 2026, 8:00 AM EDT - 2 days ago

MoonLake Immunotherapeutics Transcript: Investor Day 2026


MoonLake Immunotherapeutics Slides: FY 2026

Jun 22, 2026, 8:00 AM EDT - 2 days ago

MoonLake Immunotherapeutics Slides: FY 2026


MoonLake Immunotherapeutics Earnings release: Q1 2026

May 11, 2026, 7:00 AM EDT - 6 weeks ago

MoonLake Immunotherapeutics Earnings release: Q1 2026


MoonLake Immunotherapeutics Quarterly report: Q1 2026

May 11, 2026, 7:00 AM EDT - 6 weeks ago

MoonLake Immunotherapeutics Quarterly report: Q1 2026


MoonLake Immunotherapeutics Proxy statement: Proxy filing

Apr 21, 2026, 8:00 AM EDT - 2 months ago

MoonLake Immunotherapeutics Proxy statement: Proxy filing


MoonLake Immunotherapeutics Proxy statement: Proxy filing

Apr 21, 2026, 8:00 AM EDT - 2 months ago

MoonLake Immunotherapeutics Proxy statement: Proxy filing


MoonLake Immunotherapeutics management to meet with BTIG

2026-03-26T17:25:33.000Z - 3 months ago

MoonLake Immunotherapeutics management to meet with BTIG


MoonLake price target raised to $70 from $45 at Clear Street

2026-03-11T10:36:37.000Z - 3 months ago

MoonLake price target raised to $70 from $45 at Clear Street


MoonLake Immunotherapeutics Transcript: Investor Day 2026

Feb 23, 2026, 8:00 AM EST - 4 months ago

MoonLake Immunotherapeutics Transcript: Investor Day 2026


MoonLake Immunotherapeutics Slides: FY 2026

Feb 23, 2026, 8:00 AM EST - 4 months ago

MoonLake Immunotherapeutics Slides: FY 2026


MoonLake Immunotherapeutics Annual report: Q4 2025

Feb 22, 2026, 4:00 PM EST - 4 months ago

MoonLake Immunotherapeutics Annual report: Q4 2025


MoonLake Immunotherapeutics Earnings release: Q4 2025

Feb 22, 2026, 4:00 PM EST - 4 months ago

MoonLake Immunotherapeutics Earnings release: Q4 2025


MoonLake announces results from Phase 2 trial of Sonelokimab

2026-02-22T19:15:48.000Z - 4 months ago

MoonLake announces results from Phase 2 trial of Sonelokimab


MoonLake Immunotherapeutics Earnings release: Q3 2025

Nov 5, 2025, 4:00 PM EST - 8 months ago

MoonLake Immunotherapeutics Earnings release: Q3 2025


MoonLake Immunotherapeutics Quarterly report: Q3 2025

Nov 5, 2025, 4:00 PM EST - 8 months ago

MoonLake Immunotherapeutics Quarterly report: Q3 2025


IronManResurrection
IronManResurrection Jun. 25 at 2:22 AM
$MLTX All jokes aside Jorge is now Walkstreet’s btch! The saving grace is they’re so greedy that they will get us to $150/share BO. Sit back and watch the machine work. You don’t drop $200M on a company to not 50x that shit.
0 · Reply
Timefortendies77
Timefortendies77 Jun. 25 at 1:55 AM
$MLTX It's funny how they graciously pinned it at 20 to end the day.
0 · Reply
septrading
septrading Jun. 25 at 1:25 AM
$MLTX in less than 6 months, UBC will be utter trash and we will be king of HS and much more. Wake up, folks!
0 · Reply
septrading
septrading Jun. 25 at 1:16 AM
$MLTX I've been blocking the bears and whiners all along. And the flippers, too. We move forward knowing there is a 7x+ win ahead. If you're not holding, just move on.
2 · Reply
Obidagreat
Obidagreat Jun. 25 at 1:04 AM
0 · Reply
Kodaspappy
Kodaspappy Jun. 25 at 12:34 AM
$MLTX Retail hype never ends well for me. I just don't have the kind of luck some of you do. This is the most patient I've ever been in a stock and I will remain so. Purchases today were in the 18.90s to 19.50s.
1 · Reply
ProVest1
ProVest1 Jun. 25 at 12:32 AM
$MLTX What kind of Buffoon does NOT do an offering in the $60’s but does two offerings when the stock is depressed and worth a third of its former value that’s DE-RISKED along with all kinds of good news and positive developments? These people are idiots or are getting horrible advice. Which is it? or both?
3 · Reply
septrading
septrading Jun. 25 at 12:26 AM
$MLTX arrogant MOFO says, Pay Up!
1 · Reply
Shaybe16569
Shaybe16569 Jun. 25 at 12:19 AM
$MLTX Won’t disagree here, I think Jorge has been managing the company poorly. Or, there is strategy behind the madness. Phenomenal science, poor execution so far.
1 · Reply
Modern_portholio_theory
Modern_portholio_theory Jun. 25 at 12:03 AM
$MLTX looking back to march 2023 there are some parallels between stock price and a prospectus, where mid march price starting to rise to low to mid 20’s from low teens several months prior prospectus issues later march dropped price back to teens by april it was recovering, may new highs, and june looked great- beyond that bounced up to 50s on m and a rumour https://www.sec.gov/Archives/edgar/data/1821586/000162828023009529/moonlake424b3.htm
0 · Reply
LDCap
LDCap Jun. 24 at 10:14 PM
$MLTX the Share price is an absolute joke! If you have any dry powder this is where it goes. Best in class, best in disease and valued at less than $10 excluding cash. Anyone selling is an absolute &£#@£?.
0 · Reply
ProVest1
ProVest1 Jun. 24 at 9:54 PM
$MLTX Another way to confirm massive and gross under valuation: $580M cash deducted from the $1.47 MARKET CAP ($20) gives us $8.90 per share for the science, patents, research, and legwork. That’s a joke and an insult to my better sense. most 40% of the Market Cap is cash? I say to MOONLAKE: Get the STOCK PRICE UP or I am seeking damages for gross mismanagement and breach of Fiduciary Duty. I THINK I HAVE HAD ENOUGH OF THIS!!!
2 · Reply
Arf28
Arf28 Jun. 24 at 9:38 PM
$MLTX we were higher on June 17, how is that possible? I'll tell you how. Management is completely retarded. You can have the best business in the world but if management has no clue how to navigate capital markets then you're left with a stagnant share price as we see here. We just got HUGE news. Yet we traded higher prior to it. Sad! Shame on management for making dirt cheap offerings.
5 · Reply
AXMO
AXMO Jun. 24 at 9:27 PM
$MLTX https://ir.moonlaketx.com/node/9361/html
0 · Reply
septrading
septrading Jun. 24 at 9:26 PM
$MLTX https://www.sec.gov/Archives/edgar/data/1821586/000121390026071586/ea0295767-424b5_moonlake.htm
0 · Reply
ProVest1
ProVest1 Jun. 24 at 9:25 PM
$MLTX STRATEGY: Buy below $23 and target $32 until ACR50 (PsA) in less than a month. Target $50 to $60 up to BLA and $85 by year-end. This is a $5B company now and more than Double that by year-end IMO! Thanks friends and Best of Luck!
0 · Reply
ProVest1
ProVest1 Jun. 24 at 9:21 PM
$MLTX Some observations are in order: 1. Today’s volume of 5.3m is 59% of the 9m offering. 2. $20 is the FLOOR in the stock and is so grossly undervalued that it invites more shareholder lawsuits. 3. We printed $24 day of the release and they did the offering @$20 (SHOCKING) which shortchanged Moonlake, screwed shareholders, and insults our common sense. 4. The 9m share offering is roughly 12% dilutive after the decapitation from the low 60’s last year. 5. HS is totally DES-RISKED and totally VALIDATED, yet we trade at less than one third where it was before all this very good news being continually released all year. 6. Whom is beyond the systemic campaign to cap and suppress the stock price for the better part of a year? Why is it being shorted and for what purpose and end? Despite all being said that price doesn’t matter in a B/O, it DOES! Here’s why - You can’t do a B/O at 3 or 4 times the stock price even if the asset is a steal and supports all the BP inputs.
1 · Reply
Jkm11
Jkm11 Jun. 24 at 9:00 PM
$MLTX back over 20.
1 · Reply
InsuranceSalesman
InsuranceSalesman Jun. 24 at 8:58 PM
$MLTX We all wish we could go back to that magical time last fall when shares were 6 or 7 dollars and without a care in the world. We purchased shares because they were cheap and the company was sitting on a mountain of cash. Those times are over. Now shares are still cheap, the company will be submitting BLAs soon and 8.50 per share in cash with further results upcoming. Life was simpler then, but the science is what mattered most and it still points upward. Life is good! Ignore the trolls; their names you recognize as well as the fear they are spreading for what it is. Know what you own and be
0 · Reply
InsuranceSalesman
InsuranceSalesman Jun. 24 at 8:38 PM
$MLTX EOD short recovery team in action. Pay no attention..
0 · Reply
Shalk123
Shalk123 Jun. 24 at 8:36 PM
0 · Reply
StockQB
StockQB Jun. 24 at 8:36 PM
$MLTX Stocktwits shows 20.55 🤨
0 · Reply